How should a sessile chondroma of the proximal tibia be treated?

Treatment of Sessile Chondroma on Proximal Tibia

For a sessile chondroma (enchondroma) of the proximal tibia, the recommended treatment is intralesional curettage with or without local adjuvants (phenol, cement, or cryotherapy), which provides a high chance of local control. 1, 2, 1, 3

Treatment Algorithm

Step 1: Confirm the Diagnosis

• Distinguish between benign enchondroma and low-grade chondrosarcoma (grade I/atypical cartilaginous tumor)
• In long bones outside the hands/feet, central cartilaginous lesions should be considered low-grade chondrosarcoma until proven otherwise 3
• Pain at the lesion site may indicate malignancy 2, 3
• Contrast-enhanced MRI can reveal high-grade areas and guide biopsy site 2, 3
• Dynamic contrast-enhanced MRI aids in distinguishing benign from atypical lesions 4

Step 2: Treatment Based on Grade

For Grade I Central Chondrosarcoma/Atypical Cartilaginous Tumor in Long Bones:

• Primary option: Intralesional curettage with or without adjuvants (phenol, cement, cryotherapy) 1, 2, 1, 3, 4
• Alternative approach: Active surveillance with close radiological monitoring for asymptomatic, non-progressive lesions 4

For Higher-Grade Lesions (Grade II-III):

• Wide surgical excision with adequate margins is mandatory 1, 2, 1, 3, 4
• If wide margins cannot be achieved with limb salvage, amputation should be considered 1

Step 3: Surgical Technique for Curettage

The curettage procedure should include:

• Thorough intralesional removal of all tumor tissue
• Consider using surgical adjuvants to improve local control:
  • High-speed burr 5
  • Phenol application 1, 2, 1, 3, 4
  • Cryotherapy 1, 2, 1, 3, 5, 4
  • Cement filling 1, 2, 1, 3, 4

Critical Considerations

Location-Specific Concerns

The proximal tibia location near the growth plate in younger patients requires careful consideration 6:

• In skeletally immature patients, weigh surgical intervention against potential growth disturbance
• Consider watchful waiting if the lesion is asymptomatic and not causing functional impairment
• Surgical timing should balance tumor control with preservation of normal bone growth

Risk of Malignant Transformation

• Solitary enchondromas have ~1% risk of malignant transformation 7
• Grade progression can occur after local recurrence 5
• Warning signs include: new pain, rapid growth, cartilage cap >2 cm, or heterogeneous calcification 7

Common Pitfalls to Avoid

1. Misdiagnosis: Don't assume all cartilaginous lesions in long bones are benign—biopsy is essential for definitive diagnosis
2. Inadequate curettage: Incomplete removal increases recurrence risk; consider adjuvants to improve local control
3. Delayed intervention: While observation is acceptable for confirmed benign lesions, symptomatic or growing lesions require treatment
4. Ignoring recurrence: Local recurrence may indicate grade progression requiring more aggressive treatment 5

Follow-Up Protocol

• Regular clinical and radiological surveillance for local recurrence
• Monitor for signs of malignant transformation (pain, growth, imaging changes)
• For low-grade lesions: follow-up every 6 months for 2 years, then annually 1
• Late recurrences can occur >10 years after treatment 1

Evidence Quality Note

The guidelines consistently recommend curettage with adjuvants for grade I central chondrosarcomas in long bones across multiple ESMO publications 1, 2, 1, 3 and the most recent UK guidelines 5. The 2021 ESMO-EURACAN guidelines 4 introduce active surveillance as an alternative for asymptomatic lesions, representing an evolution in management philosophy for select cases.